Paper7985998
Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.
Schaad HJ and 4 others. Antimicrob Agents Chemother, 1994. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Papers, record 7985998. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7985998
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Therapy, Combination | Major topic |
| Foreign-Body Reaction | Major topic |
| Rifampin | Major topic |
| Staphylococcal Infections | Major topic |
| Teicoplanin | Major topic |
| Vancomycin | Major topic |
| Animals | |
| Drug Resistance, Microbial | |
| Methicillin Resistance | |
| Microbial Sensitivity Tests | |
| Rats | |
| Rats, Wistar | |
| Staphylococcus aureus |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2143434 | Resistance to vancomycin and teicoplanin: an emerging clinical problem. | Clin Microbiol Rev | 1990 | https://conductscience.org/library/papers/2143434 | PubMed |
| 2 | 2965135 | Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results. | J Antimicrob Chemother | 1988 | https://conductscience.org/library/papers/2965135 | PubMed |
| 3 | 2149812 | Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2149812 | PubMed |
| 4 | 1963526 | Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/1963526 | PubMed |
| 5 | 1826594 | Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1826594 | PubMed |
| 6 | 2128441 | Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2128441 | PubMed |
| 7 | 2150908 | Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2150908 | PubMed |
| 8 | 1903801 | Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. | J Infect Dis | 1991 | https://conductscience.org/library/papers/1903801 | PubMed |
| 9 | 1828134 | Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1828134 | PubMed |
| 10 | 1829076 | Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial. | J Antimicrob Chemother | 1991 | https://conductscience.org/library/papers/1829076 | PubMed |
| 11 | 1829079 | A review of the safety profile of teicoplanin. | J Antimicrob Chemother | 1991 | https://conductscience.org/library/papers/1829079 | PubMed |
| 12 | 1929035 | Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. | Ann Intern Med | 1991 | https://conductscience.org/library/papers/1929035 | PubMed |
| 13 | 249793 | Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. | JAMA | 1978 | https://conductscience.org/library/papers/249793 | PubMed |
| 14 | 7119479 | Pathogenesis of foreign body infection: description and characteristics of an animal model. | J Infect Dis | 1982 | https://conductscience.org/library/papers/7119479 | PubMed |
| 15 | 6827150 | Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin. | J Infect Dis | 1983 | https://conductscience.org/library/papers/6827150 | PubMed |
| 16 | 6356280 | Clinical study of combination therapy with oxacillin and rifampin for staphylococcal infections. | Rev Infect Dis | 1983 | https://conductscience.org/library/papers/6356280 | PubMed |
| 17 | 6236747 | Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6236747 | PubMed |
| 18 | 6237606 | In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6237606 | PubMed |
| 19 | 6239854 | Teicoplanin. | J Antimicrob Chemother | 1984 | https://conductscience.org/library/papers/6239854 | PubMed |
| 20 | 3965588 | Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. | J Infect Dis | 1985 | https://conductscience.org/library/papers/3965588 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36447581 | Rifaximine spacer application is not superior to local teicoplanin treatment in a rat model of osteomyelitis. | North Clin Istanb | 2022 | https://conductscience.org/library/papers/36447581 | PubMed |
| 22833247 | Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus. | Eur J Clin Microbiol Infect Dis | 2012 | https://conductscience.org/library/papers/22833247 | PubMed |
| 21189340 | Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21189340 | PubMed |
| 19364855 | Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19364855 | PubMed |
| 18724774 | The guinea pig as a model of infectious diseases. | Comp Med | 2008 | https://conductscience.org/library/papers/18724774 | PubMed |
| 16608512 | Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection. | BMC Infect Dis | 2006 | https://conductscience.org/library/papers/16608512 | PubMed |
| 16127054 | Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16127054 | PubMed |
| 15631541 | Infections associated with medical devices: pathogenesis, management and prophylaxis. | Drugs | 2005 | https://conductscience.org/library/papers/15631541 | PubMed |
| 15273106 | Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15273106 | PubMed |
| 11959588 | Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11959588 | PubMed |
| 9303384 | Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9303384 | PubMed |
| 7486895 | Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7486895 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7985998
GET https://conductscience.org/api/papers/v1/7985998/references?page=2